Baird Medical Investment Holdings (BDMD) Non-Current Assets (2023 - 2026)
Baird Medical Investment Holdings' (BDMD) quarterly Non-Current Assets came in at $28.8 million in Q2 2026, up 77.07% year-over-year from $16.2 million in Q2 2025, and up 95.25% quarter-over-quarter from $14.7 million in Q4 2025.
Analysis
Baird Medical Investment Holdings (BDMD) Non-Current Assets (2023 - 2026) Analysis & Trends
Baird Medical Investment Holdings (BDMD) has reported Non-Current Assets for 4 consecutive years, with $28.8 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Assets rose 77.07% year-over-year to $28.8 million in Q2 2026; TTM through Jun 2026 was $28.8 million, a 77.07% increase from a year earlier, with the FY2025 full-year figure at $14.7 million, down 10.97% from the prior year.
- Non-Current Assets was $28.8 million for Q2 2026 at Baird Medical Investment Holdings, up from $14.7 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $28.8 million in Q2 2026 and troughed at $14.7 million in Q4 2025.
- A 4-year average of $18.6 million and a median of $16.5 million in 2024 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets dropped 10.97% in 2025 and jumped 77.07% in 2026, its largest moves.
- Over 4 years, Non-Current Assets stood at $16.6 million in 2023, then decreased by 0.47% to $16.5 million in 2024, then declined by 10.97% to $14.7 million in 2025, then soared by 95.25% to $28.8 million in 2026.
- The last three Non-Current Assets figures came in at $28.8 million (Q2 2026), $14.7 million (Q4 2025), and $16.2 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 68.92 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 33.51 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 37.24 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 7.05 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 24.47 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 2.37 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Baird Medical Investment Holdings | 29.74 Mn | 29.45 Mn | - | 28.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.76 Mn |
| Dec 31, 2025 | 14.73 Mn |
| Jun 30, 2025 | 16.24 Mn |
| Dec 31, 2024 | 16.55 Mn |
| Dec 31, 2023 | 16.63 Mn |